Search research articles
Contact Us
Filters
Showing results (261-270 of 279) with videos related to
Page
of 28
Sort By:
Cell
|
June 2, 2021
Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever
J Maximilian Fels, Daniel P Maurer, Andrew S Herbert, et al.
Immunity
|
February 6, 2020
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization
Pavlo Gilchuk, Charles D Murin, Jacob C Milligan, et al.
The Journal of Infectious Diseases
|
August 14, 2016
Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection
Matthew L Boisen, Robert W Cross, Jessica N Hartnett, et al.
Cell Host & Microbe
|
January 11, 2019
A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates
Zachary A Bornholdt, Andrew S Herbert, Chad E Mire, et al.
Viral Immunology
|
December 23, 2014
Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreak
Matthew L Boisen, John S Schieffelin, Augustine Goba, et al.
Annals of the New York Academy of Sciences
|
October 2, 2022
Lessons from the pandemic: Responding to emerging zoonotic viral diseases-a Keystone Symposia report
Jennifer Cable, Anthony Fauci, William E Dowling, et al.
The Journal of Infectious Diseases
|
August 2, 2015
Development of Prototype Filovirus Recombinant Antigen Immunoassays
Matt L Boisen, Darin Oottamasathien, Abigail B Jones, et al.
The Journal of Infectious Diseases
|
September 3, 2016
Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection
Robert W Cross, Matthew L Boisen, Molly M Millett, et al.
Ebiomedicine
|
March 29, 2025
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials
Christopher L Cooper, Gavin Morrow, Maoli Yuan, et al.
Plos Pathogens
|
October 13, 2022
An introduction to the Marburg virus vaccine consortium, MARVAC
Robert W Cross, Ira M Longini, Stephan Becker, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 279) with videos related to
Sort By:
Page
of 28
Cell
|
June 2, 2021
Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever
J Maximilian Fels, Daniel P Maurer, Andrew S Herbert, et al.
Immunity
|
February 6, 2020
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization
Pavlo Gilchuk, Charles D Murin, Jacob C Milligan, et al.
The Journal of Infectious Diseases
|
August 14, 2016
Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection
Matthew L Boisen, Robert W Cross, Jessica N Hartnett, et al.
Cell Host & Microbe
|
January 11, 2019
A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates
Zachary A Bornholdt, Andrew S Herbert, Chad E Mire, et al.
Viral Immunology
|
December 23, 2014
Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreak
Matthew L Boisen, John S Schieffelin, Augustine Goba, et al.
Annals of the New York Academy of Sciences
|
October 2, 2022
Lessons from the pandemic: Responding to emerging zoonotic viral diseases-a Keystone Symposia report
Jennifer Cable, Anthony Fauci, William E Dowling, et al.
The Journal of Infectious Diseases
|
August 2, 2015
Development of Prototype Filovirus Recombinant Antigen Immunoassays
Matt L Boisen, Darin Oottamasathien, Abigail B Jones, et al.
The Journal of Infectious Diseases
|
September 3, 2016
Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection
Robert W Cross, Matthew L Boisen, Molly M Millett, et al.
Ebiomedicine
|
March 29, 2025
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials
Christopher L Cooper, Gavin Morrow, Maoli Yuan, et al.
Plos Pathogens
|
October 13, 2022
An introduction to the Marburg virus vaccine consortium, MARVAC
Robert W Cross, Ira M Longini, Stephan Becker, et al.
Page
of 28